Nature Reviews Clinical Oncology
Vol. 22, Issue 6
Issue 6
2025
9
Articles
Articles in this Issue
Extended neoadjuvant dostarlimab provides durable benefit in resectable dMMR solid tumours
Peter Sidaway
Jun 01, 2025
pp. 382-382
10.1038/s41571-025-01027-9
Improving outcomes of patients with pancreatic cancer
Stephan B. Dreyer, Philip Beer, Sunil R. Hingorani et al.
Jun 01, 2025
pp. 439-456
10.1038/s41571-025-01019-9
Durable responses to belzutifan in patients with VHL disease
Peter Sidaway
Jun 01, 2025
pp. 382-382
10.1038/s41571-025-01023-z
Sacituzumab tirumotecan improves OS in mTNBC
David Killock
Jun 01, 2025
pp. 382-382
10.1038/s41571-025-01022-0
Opportunities and challenges for MRD assessment in the clinical management of multiple myeloma
Bruno Paiva, Qian Shi, Noemi Puig et al.
Jun 01, 2025
pp. 424-438
10.1038/s41571-025-01017-x
HER2 testing: evolution and update for a companion diagnostic assay
Charles J. Robbins, Katherine M. Bates, David L. Rimm
Jun 01, 2025
pp. 408-423
10.1038/s41571-025-01016-y
Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers
Margherita Ambrosini, Paolo Manca, Vincenzo Nasca et al.
Jun 01, 2025
pp. 385-407
10.1038/s41571-025-01015-z
Hodgkin lymphoma: great progress with room for improvement
Paul J. Bröckelmann
Jun 01, 2025
pp. 379-381
10.1038/s41571-025-01012-2
MORPHEUS-Liver provides a way forward in expanding the immunotherapy options for hepatocellular carcinoma
Bruno Sangro, Josepmaria ArgemÃ
Jun 01, 2025
pp. 383-384
10.1038/s41571-025-01009-x
All Issues
Journal Info
Publisher
Springer Science and Business Media LLC
ISSN
1759-4774
E-ISSN
1759-4782
Subject
Medicine
Language
English